1. Home
  2. FUNC vs VCRE Comparison

FUNC vs VCRE Comparison

Compare FUNC & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First United Corporation

FUNC

First United Corporation

SELL

Current Price

$43.81

Market Cap

282.0M

Sector

Finance

ML Signal

SELL

Logo Vicore Pharma Holding AB American Depositary Shares

VCRE

Vicore Pharma Holding AB American Depositary Shares

HOLD

Current Price

$9.26

Market Cap

271.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUNC
VCRE
Founded
1900
2000
Country
United States
Sweden
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
282.0M
271.7M
IPO Year
2012
2026

Fundamental Metrics

Financial Performance
Metric
FUNC
VCRE
Price
$43.81
$9.26
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
★ $50.00
$29.03
AVG Volume (30 Days)
★ 27.9K
24.8K
Earning Date
10-23-2026
11-05-2026
Dividend Yield
★ 2.60%
N/A
EPS Growth
★ 19.68
N/A
EPS
★ 1.90
N/A
Revenue
★ $18,426,000.00
N/A
Revenue This Year
$9.57
$101.29
Revenue Next Year
$6.10
$481.15
P/E Ratio
$22.84
★ N/A
Revenue Growth
★ 4.01
N/A
52 Week Low
$33.54
$7.88
52 Week High
$46.30
$14.01

Technical Indicators

Market Signals
Indicator
FUNC
VCRE
Relative Strength Index (RSI) 50.32 45.56
Support Level $43.30 $8.79
Resistance Level $45.71 $12.08
Average True Range (ATR) 1.12 0.85
MACD 0.02 0.00
Stochastic Oscillator 45.13 41.50

Price Performance

Historical Comparison
FUNC
VCRE

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

About VCRE Vicore Pharma Holding AB American Depositary Shares

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

Share on Social Networks: